DHB: Lean Gains, Reported Doses and Injection Pain
DHB, at a glance
People consider DHB for muscle fullness, strength and a leaner-looking physique. It also attracts people looking for an alternative to Primo. Injection pain is the practical downside that can overshadow those goals.
Some report good strength and appearance changes; others stop because of pain, fatigue or feeling unwell. That mixed experience does not establish a safer version of Tren or a stronger version of Primo.
Less interest in scale weight; more in shape and definition.
Some report pain severe enough to affect training.
Changes people hope to notice in the gym.
Experiences vary, including reports of little benefit.
Reported experiences. No human trial establishes “stronger Primo” or “Tren without the sides.”
Reported amount and cycle length
There is no established human DHB injection regimen in the research checked here. The examples below describe nonmedical use, with unverified products and other steroids involved.
250 mg/week
Total weekly amount
One proposed plan included testosterone and oral steroids. The injection split was not specified.
12 planned weeks
Planned duration
A proposal, not a report of completing that course or evidence that this length is safe.
Separate nonmedical advice includes 300–450 mg/week suggestions. These are another reported example, not a studied range, starting dose or dose-equivalence to Primo or Tren.
DHB vs Primo or Tren: what are people comparing?
Usually appearance, strength and tolerability, rather than the same measured outcome. A fuller or harder look is not the same as adding more muscle, and comfort while using a product is not a complete safety assessment.
- Compared with Primo: people look for a similar lean, full appearance. A reliable milligram-for-milligram conversion has not been established.
- Compared with Tren: “Tren without the sides” promises a benefit-to-risk balance that human comparative research has not demonstrated.
- For a cut or a bulk: diet, training, starting body fat and the other drugs in a stack make results difficult to attribute to DHB alone.
What about injection pain?
PIP means post-injection pain. Some people describe little discomfort; others report lumps or pain that affects movement and training. Neither experience verifies the contents of a vial.
The actual preparation matters: carrier oil, solvents, concentration and product quality differ. Reports do not establish one explanation for every painful injection, or a guaranteed fix from heating, diluting or changing the carrier.
Painful, hot or swollen skin needs prompt medical assessment, especially if it is worsening or you feel unwell. Infection should not be dismissed as routine PIP. NHS: cellulitis symptoms
Where the half-life estimate fits
A cypionate ester changes release, but a testosterone-cypionate half-life is not automatically a DHB half-life. The formulation and route matter too.
The DHB compound guide keeps its timing assumptions available. A relative curve can illustrate overlap; it cannot predict muscle gain, injection comfort or a blood-test result.
What direct research shows
DHB is also called 1-testosterone. It is an active steroid, not ordinary testosterone. Receptor and rat research supports anabolic-androgenic activity, including effects on reproductive tissues and increased liver weight. It does not establish human injection safety or a muscle-gain ranking. Friedel et al., 2006
DHB, DHB cypionate and 1-andro are different labels
Check which product is being described
| Compare | What it means | Why it matters |
|---|---|---|
| DHB / 1-testosterone | The active steroid molecule | Not ordinary testosterone |
| DHB cypionate | DHB with a cypionate ester | The injectable preparation affects release |
| 1-andro / 1-DHEA | A precursor used in some supplements | Not an interchangeable amount of injected DHB |
The often-cited human resistance-training trial tested an oral prohormone supplement in 17 men for four weeks. It was not a trial of injected DHB cypionate, so its muscle or laboratory outcomes cannot be transferred directly to that product. Granados et al., 2014
Common questions
Does a leaner look mean no hormone-related effects? No. Appearance cannot tell you whether natural hormone production, cholesterol or other health markers are affected. A non-aromatizing reputation is not a general safety guarantee.
Does a good blood test prove the product is harmless? No. One result cannot rule out other effects, and feeling well does not verify product identity.
Sources and review notes
Checked October 11, 2026. Community experiences inform the questions and reported-use examples; they do not establish how often an effect occurs or a safe regimen. No controlled human injectable-DHB comparison was found in this pass.
- Friedel et al., 2006: original receptor and animal study; active-steroid identity and preclinical effects.
- Granados et al., 2014: original oral prohormone study, not injected DHB.
- NHS cellulitis guidance: painful, hot and swollen skin warrants urgent assessment; it does not diagnose a particular injection reaction.
Related compounds & model context
Article citations are linked in the text. Related catalog entries have separate model inputs and source notes, which may include unverified estimates. See our methodology for model assumptions and limitations.